Trial Outcomes & Findings for SMS HPV Vaccine Reminders (NCT NCT05151367)
NCT ID: NCT05151367
Last Updated: 2024-07-08
Results Overview
Timeliness of vaccination will be measured by the number of participants who received the next HPV vaccine dose.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
154 participants
Primary outcome timeframe
Up to 6 months from randomization
Results posted on
2024-07-08
Participant Flow
Participant milestones
| Measure |
Text Message Reminders
Text message reminders
Text message reminder: Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)
|
Usual Care
No reminders
|
|---|---|---|
|
Overall Study
STARTED
|
78
|
76
|
|
Overall Study
COMPLETED
|
78
|
76
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
SMS HPV Vaccine Reminders
Baseline characteristics by cohort
| Measure |
Text Message Reminders
n=78 Participants
Text message reminders
Text message reminder: Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)
|
Usual Care
n=76 Participants
No reminders
|
Total
n=154 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
10 years
|
15 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
32 Participants
n=5 Participants
|
|
Age, Customized
11 years
|
20 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
38 Participants
n=5 Participants
|
|
Age, Customized
12 years
|
19 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
|
Age, Customized
13 years
|
17 Participants
n=5 Participants
|
23 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Age, Customized
14 years
|
7 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
78 Participants
n=5 Participants
|
76 Participants
n=7 Participants
|
154 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
78 Participants
n=5 Participants
|
76 Participants
n=7 Participants
|
154 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
Uganda
|
78 participants
n=5 Participants
|
76 participants
n=7 Participants
|
154 participants
n=5 Participants
|
|
Language
English
|
28 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
55 Participants
n=5 Participants
|
|
Language
Luganda
|
50 Participants
n=5 Participants
|
49 Participants
n=7 Participants
|
99 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 6 months from randomizationTimeliness of vaccination will be measured by the number of participants who received the next HPV vaccine dose.
Outcome measures
| Measure |
Text Message Reminders
n=78 Participants
Text message reminders
Text message reminder: Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)
|
Usual Care
n=76 Participants
No reminders
|
|---|---|---|
|
Number of Participants Who Received the Next HPV Vaccine Dose
|
51 Participants
|
27 Participants
|
Adverse Events
Text Message Reminders
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Usual Care
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place